LLY
Eli Lilly & Co.
LLY: this snapshot in plain language
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant… The recorded LLY quote is $1,352.83, up 0.13% in the reported session. Recorded market capitalization is $1,203.50B. StockMarketLoop’s market-position model reads 48.85%.
What to watch
- The model’s recorded reference range is $1,158.54 support to $1,417.94 resistance. Watch whether a fresh quote holds the lower level or tests the upper level.
Source: StockMarketLoop materialized market snapshot. The upstream provider is not recorded in this snapshot. Observed . Automated summary by StockMarketLoop · Methodology and corrections.
What is a short squeeze?
A short squeeze can occur when a rising price or difficulty borrowing shares leads short sellers to buy shares to close positions, adding buying pressure. High short interest alone does not establish that a squeeze is imminent. SEC: short selling.
What does options flow show?
Options flow is reported options-trading activity. Volume counts trading activity; open interest counts contracts still open. A print alone may not establish whether a position is opening, closing or a hedge. Calls and puts do not by themselves prove trade direction or profitability. OCC/OIC: volume and open interest.
About Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Explore LLY
Open the interactive ticker terminal for charts, technical tools, market discussion and live modules.
Open LLY ticker terminal